Glober G A, Cantrell E G, Doll R, Peto R
Gut. 1971 Jul;12(7):570-3. doi: 10.1136/gut.12.7.570.
ABO and Rhesus blood group data have been examined for 1,680 patients treated for gastric cancer in four London hospitals. The risk of developing gastric cancer was estimated to be 16% higher for group A subjects than for group O subjects, in close agreement with many previous reports throughout the world. More detailed analysis failed to support the suggestion that there was any special correlation between either ABO or Rhesus blood groups and the site of origin of the tumour within the stomach or the sex or age of the patient. Male predominance among the patients was noted to be greater at ages 40-69 years than at other ages and greater for tumours of the upper two thirds of the stomach than for tumours that arose distally.
对伦敦四家医院接受胃癌治疗的1680名患者的ABO和恒河猴血型数据进行了检查。据估计，A血型受试者患胃癌的风险比O血型受试者高16%，这与世界各地许多先前的报告密切一致。更详细的分析未能支持ABO血型或恒河猴血型与胃内肿瘤起源部位、患者性别或年龄之间存在任何特殊关联的说法。值得注意的是，40至69岁患者中的男性优势比其他年龄段更大，胃上三分之二部位的肿瘤患者中的男性优势比远端发生的肿瘤患者更大。
